Non-Accredited Education
Understanding Collagen Dressings and their Benefit in Wound Care Complimentary Archived Webcast
Non-Accredited
Issue
- Issue:7
July, 2005
Dear Readers,
In the first article of this issue, Junko et al. (Pressure-induced ischemic wound healing with bacterial inoculation in the rat) report on a new animal model for pressure ulcers. There have been other publications of animal models for pressure ulcers, and the authors discuss these studies. In the present report, the effects of bacterial contamination and subsequent infection are studied in pressure-induced rat wounds. Compared to the pressure-wound-only control group, the inoculated group showed greater tissue necrosis and slower healing. It is suggested b
- Issue:7
W ith unrelieved pressure, tissue ischemia develops, and metabolic wastes accumulate in the interstitial tissue, resulting in anoxia and cellular death.1 This pressure-induced ischemia also leads to excessive tissue hypoxia, further promoting bacterial proliferation and tissue destruction.2 In clinical settings, some pressure-induced ischemic wounds are caused by support surfaces, and some lower-limb diabetic pressure ulcers are caused by footwear. Infection of these wounds considerably impairs the healing process. For example, with pressure ulcers, the prevalence of inf
- Issue:7
N ecrotizing lesions of soft tissue are infrequently encountered in routine surgical practice. The term necrotizing fasciitis unites different syndromes of progressive gangrenous infections of the skin and subcutaneous tissue into a single category.1 It is a rare, rapidly progressive infection that affects the fascia and subcutaneous tissue concomitantly with the development of thrombosis of skin microcirculation, resulting in necrosis of skin and soft tissue, destruction of muscles, and liquefaction of fats.1,2
The treatment is complex. The priority lies in an - Issue:7
M any diseases show a chronic course, and among them, chronic venous insufficiency is considered to be the most common disorder of venous origin.1,2 Chronic venous insufficiency refers to a set of physical alterations that occur on the skin and in subcutaneous tissue, mainly affecting the lower limbs, and manifest as edema, hyperpigmentation, eczema, and lipodermatosclerosis.3 These manifestations are the result of long-term venous hypertension caused by valvular insufficiency and/or venous obstruction with skin ulceration as a complication.1,3–6 Ulcers of v
- Issue:7
S ibbald et al.1 and Falanga2 first defined wound bed preparation (WBP) in 2000. Schultz et al.3 expanded the definition in 2003. Wound bed preparation can be described as the management of the wound to accelerate endogenous healing or to facilitate the effectiveness of other therapeutic measures. There are 5 basic modes of debridement: sharp, mechanical, enzymatic, autolytic, and biological (maggot therapy). A given mode is generally chosen based upon the need of the patient, the care setting, and the licensure of the practitioner. There have been many option
- Issue:7
Presentation
A 63-year-old white woman presented with a rash on all extremities and the face, conjunctivitis, and painful perioral and oral mucosal erosions. She denied pharyngeal or esophageal dysphagia. The patient was afebrile and denied weakness, malaise, or other constitutional symptoms. Her past medical history was significant for lung cancer, diagnosed 1 year prior to presentation, which was currently in remission. The patient also had a past medical history of dry eye syndrome and hypertension. She underwent initial chemotherapy followed by maintenance therapy with gefitinib (Iress
- Issue:7
SilverDerm7 Nylon Wound Dressing Does Not Shed Silver Material
DermaRite Industries (Paterson, NJ) has added SilverDerm7 to the company’s line of wound care dressings.
The dressing surface is 99.9% pure metallic silver, autocatalytic plated to pure nylon, and designed to not shed the silver material. The dressing passively delivers the silver ion in the presence of moisture where, in turn, the ion disassociates itself from the metallic surface and attaches to the fluid. The dressing will never stain or tattoo the skin, because the metallic surface is not deposited into the tissue.
T - Issue:7
HEALTHPOINT’s Spray Delivery System Recognized as a New Medical Technology by Novation
The spray delivery systems Accuzyme® Spray (Papain, Urea) and Panafil® Spray (Papain, Urea, Chlorophyllin Copper Complex Sodium) from HEALTHPOINT® (Fort Worth, Tex) have been recognized as new medical technologies by the Novation Wound Care Management Council (Irving, Tex).
Novation is the supply company of VHA Inc. and the University HealthSystem Consortium (UHC). Novation is committed to ensuring that VHA and UHC members have access to information about new and potentially innovative healthcare
Press Release
ConvaTec and Boehringer Technologies Announce License Agreement
ConvaTec Acquires Exclusive Worldwide Rights for a Negative Pressure Wound Therapy System
SKILLMAN, NJ (December 18, 2008) — ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, announced today it has signed a long-term global exclusive license agreement with Boehringer Technologies to market and distribute Boehringer’s Engenex® Negative Pressure Wound Therapy (NPWT) System incorporating Bio-Dome™ Interface Technology.
WOUNDS News Wire
- Friday, December 5, 2008 - 15:08
- Wednesday, October 22, 2008 - 15:28
- Wednesday, October 22, 2008 - 15:25
CME Showcase
"Diabetic Peripheral Neuropathy"
Upcoming Accredited Webcast Release Date: December 22, 2008 Expiration Date: December 22, 2009 This activity is supported by an educational grant from PamLabs. To register for this Webcast, visit www.naccme.com/program/n-558/ |
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
Upcoming Live Accredited Webcast with Q&A Noon to 1 p.m. EDT January 20, 2009 Rebroadcasts 7:30-8:30 p.m. EDT 3-4 p.m. EDT This activity is supported by an educational grant from Advanced Biohealing. To register for this Webcast, visit www.naccme.com/program/n-550/ |
| MRSA And Diabetic Foot Wounds: Where Do We Go From Here? Accredited Webcast Archive Version available now. This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
|
PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI): Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Maintenance Debridement: A New Look at Science and Art Accredited Webcast with Q&A: November 17, 2008 at 3:00pm EST This activity is supported by an educational grant from HealthPoint Ltd. |
REVIEW OUR OTHER
WOUND CARE BRANDS
Check out our other resources for healthcare professionals of all specialties.
